ABEV · Ambev S.A.

This 6-K filing discloses Ambev S.A.'s monthly securities transaction report for April 2026, mandated under CVM Instruction #44/2021. The company executed 13 identical purchases of 2,000,000 common shares each — all through Santander Corretora — resulting in a total acquisition of 20 million shares. The weighted average purchase price was approximately R$15.62 per share, and the aggregate volume totaled R$317.7 million. The increase in treasury shares from 166,970,849 to 190,970,849 reflects a deliberate capital allocation decision, though the filing does not specify whether this activity falls under an announced buyback program or ad hoc repurchases. Notably, no ADRs were acquired or held, reinforcing that these transactions were conducted solely in the Brazilian market and did not involve U.S. depositary receipts. While no forward guidance, earnings metrics, or executive changes are included, the scale and consistency of the purchases — daily or near-daily execution over 10 trading days — signal sustained investor confidence and balance sheet strength. For U.S. investors, this represents tangible capital return activity, albeit without disclosure of funding source, strategic rationale, or remaining authorization.